Truveta Data expands beyond EHR data with linked closed claims for more than 200 million patients
13 févr. 2025 09h00 HE
|
Truveta
BELLEVUE, Wash., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Today, Truveta announced the expansion of Truveta Data with the addition of new commercial, Medicare, and Medicaid closed claims on more than 200...
New Truveta study highlights patterns of discontinuation and reinitiation of GLP-1 RA medications
31 janv. 2025 11h18 HE
|
Truveta
BELLEVUE, Wash., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Truveta’s groundbreaking study analyzing real-world use of GLP-1 receptor agonist (GLP-1 RA) therapies in adults with overweight or obesity has...
Leading US health systems launch the Truveta Genome Project, creating the world’s largest and most diverse database to discover the science of humanity
13 janv. 2025 06h00 HE
|
Truveta
BELLEVUE, Wash., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Today, leading US health systems, including Advocate Health, CommonSpirit Health, Henry Ford Health, Northwell Health, Providence, and Trinity...
Truveta achieves HITRUST r2 Certification, demonstrating the highest level of information protection assurance
20 nov. 2024 09h00 HE
|
Truveta
BELLEVUE, Wash., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Truveta announced that its platform Truveta Studio and Truveta Data have earned certified status by HITRUST for information security. This...
Truveta Data, the most complete, timely, and clean electronic health record data, now includes more than 120 million de-identified patients
14 nov. 2024 09h53 HE
|
Truveta
BELLEVUE, Wash., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Truveta announced today that Truveta Data, the most complete, timely, and clean electronic health record (EHR) data, now includes more than 120...
Truveta Studio now includes Truveta Tru, a research assistant powered by generative AI
29 oct. 2024 09h18 HE
|
Truveta
BELLEVUE, Wash., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Today, Truveta announced its latest AI innovation – Truveta Tru, Truveta Studio’s research assistant powered by generative AI. Trained on the...
The CHOICE Institute partners with Truveta to advance health economics and outcomes research
04 sept. 2024 09h00 HE
|
Truveta
BELLEVUE and SEATTLE, Wash., Sept. 04, 2024 (GLOBE NEWSWIRE) -- The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington’s School of Pharmacy has...
Truveta’s real-world data study comparing tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss published in JAMA Internal Medicine
08 juil. 2024 11h16 HE
|
Truveta
BELLEVUE, Wash., July 08, 2024 (GLOBE NEWSWIRE) -- Today Truveta announced that its comparative effectiveness study exploring weight loss among patients taking semaglutide (Ozempic) and tirzepatide...
Truveta announces support for regulatory submissions to the FDA and global regulatory authorities
18 juin 2024 11h13 HE
|
Truveta
BELLEVUE, Wash., June 18, 2024 (GLOBE NEWSWIRE) -- Today, Truveta announced regulatory and audit capabilities to support its customers for real-world evidence (RWE) submissions to the Food and Drug...
Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as new Truveta Board of Directors Chair
13 mai 2024 09h00 HE
|
Truveta
BELLEVUE, Wash., May 13, 2024 (GLOBE NEWSWIRE) -- Today Truveta, a growing collective of more than 30 health systems with a mission of Saving Lives with Data, welcomes Rod Hochman, MD, president and...